Respiratory Care: Noninvasive Ventilation and Airway Management Products
Respiratory Care: Noninvasive Ventilation and Airway Management Products
$4,750.00
Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Highlights
- In 2019, global sales of the positive airway pressure (PAP)-based noninvasive ventilation (NIV) products and airway management accessories covered by this report totaled approximately $6.7bn; of this, PAP-based NIV products accounted for an estimated 70.1% of sales and airway management accessories accounted for the remaining 29.9% of sales.
- Over the forecast period covered by this report, combined sales are expected to increase at a CAGR of 8.3%, reaching nearly $10.0bn in 2024 and combining 8.4% growth in the PAP-based NIV products market and 8.0% growth in the airway management accessories market. These growth rates are above traditional (mid-single-digit) growth rates for these markets due to a COVID-related surge in sales in 2020–21, with a return to more typical growth rates anticipated in 2022.
- In the PAP-based NIV products market, this surge is due to increased hospital use of BiPAP devices for COVID-19 treatment along with continuing mask resupply sales for existing apnea patients. In the airway management accessories market, the surge is due to increased demand for respiratory accessories rising with the COVID-19 pandemic, as more ventilated and nonventilated patients require accessories to maintain moistened respiratory mucosa.
Key topics covered
- This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the PAP-based NIV and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).
Overview
Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors). This report covers the global market including the US, five major European markets (France, Germany, Italy, Spain, and the UK) for 2019–24. In 2019, combined global sales of the PAP-based NIV products and airway management accessories covered by this report totaled nearly $7bn, with NIV products accounting for more than two-thirds of total sales. Sales are expected to increase at a CAGR of 7.6%, reaching nearly $10bn in 2024. COVID-19 is expected to cause a surge in sales of these products in 2020–21 as less invasive ventilation devices gain popularity in treating patients in respiratory distress, and as demand for airway management accessories such as HMEs, humidifiers, and nebulizers rises with the increase in ventilated patients.
Table of Contents
Executive Summary …………………………………………………………………….. ES-1
i. PAP-based noninvasive ventilation products ………………………………………………………. ES-1
ii. Airway management accessories……………………………………………………………………… ES-2
iii. Market analysis ……………………………………………………………………………………………. ES-3
iv. Major competitors………………………………………………………………………………………… ES-6
v. Methodology………………………………………………………………………………………………… ES-7
vi. Bibliography ………………………………………………………………………………………………… ES-9
Exhibit ES-1: PAP-based noninvasive ventilation products and airway management accessories, market forecast ($m), 2019–24 ……………………………………………….. ES-5
1. Respiratory Disease Overview ……………………………………………………..1-1
1.1 Asthma…………………………………………………………………………………………………………1-1
1.1.1 Etiology…………………………………………………………………………………………..1-1
1.1.2 Epidemiology…………………………………………………………………………………..1-2
1.2 Chronic obstructive pulmonary disease ……………………………………………………………..1-2
1.2.1 Etiology…………………………………………………………………………………………..1-3
1.2.2 Epidemiology…………………………………………………………………………………..1-3
1.3 Coronavirus disease 2019………………………………………………………………………………..1-4
1.3.1 Etiology…………………………………………………………………………………………..1-4
1.3.2 Epidemiology…………………………………………………………………………………..1-5
1.4 Bibliography………………………………………………………………………………………………….1-8
Exhibit 1-1: Asthma epidemiology, 2016 and 2036 ……………………………………………………1-2
Exhibit 1-2: COPD epidemiology, 2018 and 2038 ………………………………………………………1-4
Exhibit 1-3: COVID-19 epidemiology, 2020 ………………………………………………………………1-7
2. Positive Pressure-Based Noninvasive Ventilation Products………………..2-1
2.1 Products and technology …………………………………………………………………………………2-2
2.1.1 Philips Healthcare/Koninklijke Philips…………………………………………………..2-3
2.1.2 ResMed ………………………………………………………………………………………….2-4
2.1.3 Fisher & Paykel Healthcare…………………………………………………………………2-4
2.1.4 Other suppliers………………………………………………………………………………..2-5
2.2 Market analysis……………………………………………………………………………………………..2-7
2.3 Competitive analysis……………………………………………………………………………………….2-9
2.3.1 Philips Healthcare/Koninklijke Philips…………………………………………………..2-9
2.3.2 ResMed ………………………………………………………………………………………..2-10
2.3.3 Fisher & Paykel Healthcare……………………………………………………………….2-12
2.3.4 Other competitors ………………………………………………………………………….2-13
2.4 Emerging technologies………………………………………………………………………………….2-14
2.4.1 Respicardia: remedē system …………………………………………………………….2-14
2.4.2 LivaNova: THN Sleep Therapy system…………………………………………………2-15
2.4.3 Beyond Air: LungFit system………………………………………………………………2-15
2.4.4 KeepMed and Mérieux Equity Partners: keePAP system………………………..2-15
2.5 Bibliography………………………………………………………………………………………………..2-16
Exhibit 2-1: Selected noninvasive ventilation products, 2020………………………………………2-6
Exhibit 2-2: PAP-based noninvasive ventilation products, market forecast ($m), by region, 2019–24……………………………………………………………………………………2-8
Exhibit 2-3: Koninklijke Philips, revenues by segment, FY2019…………………………………..2-10
Exhibit 2-4: ResMed, revenues by segment, FY2020 ………………………………………………..2-11
Exhibit 2-5: Fisher & Paykel Healthcare, revenues by segment, FY2020 ………………………2-13
Exhibit 2-6: PAP-based noninvasive ventilation products market, share by supplier, 2019 ……………………………………………………………………………2-14
3. Airway Management Accessories …………………………………………………3-1
3.1 Heat and moisture exchangers…………………………………………………………………………3-1
3.1.1 Products and technology……………………………………………………………………3-1
3.1.2 Market analysis………………………………………………………………………………..3-3
3.1.3 Competitive analysis…………………………………………………………………………3-6
3.2 Humidifiers……………………………………………………………………………………………………3-9
3.2.1 Products and technology………………………………………………………………….3-10
3.2.2 Market analysis………………………………………………………………………………3-13
3.2.3 Competitive analysis……………………………………………………………………….3-14
3.3 Nebulizers…………………………………………………………………………………………………..3-18
3.3.1 Large-volume nebulizers………………………………………………………………….3-19
3.3.2 Small-volume nebulizers………………………………………………………………….3-19
3.3.3 Nebulizer compressors…………………………………………………………………….3-20
3.3.4 Market analysis………………………………………………………………………………3-24
3.3.5 Competitive analysis……………………………………………………………………….3-25
3.4 Emerging technologies………………………………………………………………………………….3-30
3.5 Combined market analysis……………………………………………………………………………..3-31
3.6 Bibliography………………………………………………………………………………………………..3-33
Exhibit 3-1: Selected heat and moisture exchangers, 2020 …………………………………………3-3
Exhibit 3-2: Heat and moisture exchangers, market forecast ($m), by region, 2019–24 …..3-5
Exhibit 3-3: Teleflex, revenues by segment, FY2019…………………………………………………..3-7
Exhibit 3-4: Smiths Group, revenues by segment, FY2020…………………………………………..3-8
Exhibit 3-5: Heat and moisture exchangers market, share by supplier, 2019………………….3-9
Exhibit 3-6: Selected humidifiers, 2020………………………………………………………………….3-12
Exhibit 3-7: Humidifiers, market forecast ($m), by region, 2019–24……………………………3-14
Exhibit 3-8: Fisher & Paykel Healthcare, revenues by segment, FY2020 ………………………3-16
Exhibit 3-9: ResMed, revenues by segment, FY2020 ………………………………………………..3-17
Exhibit 3-10: Humidifiers market, share by supplier, 2019………………………………………..3-18
Exhibit 3-11: Selected nebulizers, 2020 …………………………………………………………………3-22
Exhibit 3-12: Nebulizers, market forecast ($m), by region, 2019–24 …………………………..3-25
Exhibit 3-13: Koninklijke Philips, revenues by segment, FY2019…………………………………3-27
Exhibit 3-14: Omron, revenues by segment, FY2019………………………………………………..3-29
Exhibit 3-15: Nebulizers market, share by supplier, 2019………………………………………….3-30
Exhibit 3-16: Airway management accessories, combined market forecast ($m), by segment, 2019–24 ………………………………………………………………………………3-32
Appendix: Company Lisitng……………………………………………………………. A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Extremity Replacement Implants 
Sign up to the